Skip to content

Effects of propofol and etomidate on hemodynamics during anesthesia induction in elderly hypertensive patients: a randomized controlled trial

Comparative study of the effects of propofol and etomidate on hemodynamics during anesthesia induction in elderly patients with hypertension

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500108049
Enrollment
Unknown
Registered
2025-08-22
Start date
2025-09-01
Completion date
Unknown
Last updated
2025-08-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertensive surgery patients

Interventions

Group C:Anesthesia induction using ciprofol
Group E:Anesthesia induction using etomidate

Sponsors

Jiangxi Provincial People's Hospital (The First Affiliated Hospital of Nanchang Medical College)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Patients aged 65-80 years, regardless of gender, with a body mass index (BMI) of 18.5-25 kg/m^2; (2) Patients were awake before surgery, underwent elective surgery, and underwent general anesthesia with endotracheal intubation; (3) Patients were classified as American Society of Anesthesiologists (ASA) grade II-III and Mallampati airway grade I-II before surgery; (4) Patients had no severe heart, lung, brain, or other major organ diseases, and no significant abnormalities in liver and kidney function; (5) Patients were diagnosed with hypertension (grade 1 or above)

Exclusion criteria

Exclusion criteria: (1) Patients with high-degree atrioventricular block requiring pacemaker implantation or severe arrhythmia; (2) Patients who have long-term use of nonsteroidal anti-inflammatory drugs, narcotic analgesics or sedatives; (3) History of cerebral or thoracic/abdominal aortic aneurysm; (4) Allergy to any drug used in the study; (5) History of severe liver damage, i.e. Child-Pugh B or C; (6) Patients undergoing maintenance dialysis; (7) Congestive heart failure; (8) Untreated or unstable ischemic heart disease; (9) History of severe aortic valve or mitral valve disease; (10) Presence or anticipated presence of difficult airway;

Design outcomes

Primary

MeasureTime frame
Area under the curve (AUC) of the difference between MAP and baseline in the first 10 minutes after induction;Incidence of hypotension;

Secondary

MeasureTime frame
LOC and BIS less than 60 time;Number of patients receiving supplementary medication;Use of vasoactive drugs;

Countries

China

Contacts

Public ContactJinhui-Xu

Jiangxi Provincial People's Hospital (The First Affiliated Hospital of Nanchang Medical College)

mzkxjh@163.com+86 152 7916 7137

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026